Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Uncommon Human Telomerase Reverse Transcriptase Promoter Mutations Are Associated With Poor Survival in Ovarian Clear Cell Carcinoma.

American journal of clinical pathology - 7 Mar 2018

Nishikimi Kyoko, Nakagawa Kiyoshi, Tate Shinichi, Matsuoka Ayumu, Iwamoto Masami, Kiyokawa Takako, Shozu Makio

Abstract excerpt

OBJECTIVES: The present study assessed whether human telomerase reverse transcriptase (TERT) promoter mutations mediate the increased mortality risk observed in patients with ovarian clear cell carcinoma (CCC) and characterized the pathologic features of TERT promoter mutation-associated ovarian CCC. METHODS: The TERT promoter region in genomic DNA extracted from paraffin-embedded ovarian CCC specimens (n = 93)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma, Clear Cell
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma, Ovarian Epithelial

Share to Neoplasms, Glandular and Epithelial

Share to Ovarian Neoplasms

Share to Promoter Regions, Genetic

Share to Survival Analysis

Share to Telomerase

Source

Identifiers

PMID: 29474637
DOI: 10.1093/ajcp/aqx166

Genes

TERT

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Uncommon Human Telomerase Reverse Transcriptase Promoter Mutations Are Associated With Poor Survival in Ovarian Clear Cell Carcinoma.PMID 29474637Read ↗

Clinicopathological and Prognostic Values of Telomerase Reverse Transcriptase (TERT) Promoter Mutations in Ovarian Clear Cell Carcinoma for Predicting Tumor Recurrence, Platinum Resistance and Survival.Semantic proximity Read ↗

Frequent somatic mutations of the telomerase reverse transcriptase promoter in ovarian clear cell carcinoma but not in other major types of gynaecological malignancy.Semantic proximity Read ↗

Molecular alterations in endometrial and ovarian clear cell carcinomas: clinical impacts of telomerase reverse transcriptase promoter mutation.Semantic proximity Read ↗

Characterization and Impact of TERT Promoter Region Mutations on Clinical Outcome in Renal Cell Carcinoma.Semantic proximity Read ↗

TERT promoter mutations in clear cell renal cell carcinoma.Semantic proximity Read ↗

Suppressor-type TERT mutations associated with recurrence in ovarian clear cell carcinoma.Semantic proximity Read ↗

Molecular profiling reveals novel therapeutic targets and clonal evolution in ovarian clear cell carcinoma.Semantic proximity Read ↗

Promoter mutations and cellular distribution of telomerase in non-clear cell and clear cell hepatocellular carcinoma.Semantic proximity Read ↗

Telomerase reverse transcriptase promoter mutations in hepatitis B virus-associated hepatocellular carcinoma.Semantic proximity Read ↗

The -124C>T mutation of TERT promoter indicated a favorable prognosis in OCCC: a monoinstitutional study in ChinaSemantic proximity Read ↗

Common telomerase reverse transcriptase promoter mutations in hepatocellular carcinomas from different geographical locations.Semantic proximity Read ↗

Telomerase reverse transcriptase promoter mutations in tumors originating from the adrenal gland and extra-adrenal paraganglia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.